Post COVID-19 Global Vaccination Strategies, Target Populations and Public Health Vaccines Portfolio

CHALLENGE

A pharmaceutical client engaged a niche consulting firm to delve into post COVID-19 global vaccination strategies, target populations, and the public health vaccines portfolio. The aim was to acquire a detailed understanding of the evolving vaccination landscape and its implications for public health, to guide strategic investment and development decisions.

BTHT APPROACH

After an in-depth initial consultation with the consulting firm and a clear definition of the project's objectives, the BTHT team quickly identified the most relevant experts. They reached out to former government officials and key opinion leaders (KOLs) with extensive backgrounds in public health and vaccination policy. The BTHT team organized and facilitated a series of in-depth expert calls, ensuring each discussion was insightful and free of technical disruptions.

OUTCOME

The BTHT team’s diligent efforts enabled the client to connect with highly experienced former government officials and KOLs, who provided critical insights into the global vaccination landscape. These expert calls delivered essential information on vaccination strategies, target populations, and the public health vaccines portfolio. The insights gained were invaluable for the client, equipping them with the knowledge needed to navigate the post COVID-19 environment and make informed decisions regarding their public health strategies and investments.